Our results revealed that MMP-2 and MMP-9 expression in glioma cells were increased at both the RNA and protein levels after NE treatment, whereas CD147 silencing inhibited MMP-2 and MMP-9 expression (P<0.05) (Figures 2E–H). Here, MMP2 is linked to glioma.